BioPhenoMA Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 5

BioPhenoMA General Information

Description

Developer of a quantification service platform designed to analyze and detect ultra-trace proteins. The company provides high-sensitivity quantification services to support the research and development of pharmaceuticals, quasi-drugs and reagents, enabling the healthcare industry to research and contribute further to the biomedical field.

Contact Information

Website
www.biophenoma.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Waseda University Entrepreneurship Center
  • 1-22-3 Nishiwaseda, Shinjuku-ku
  • Tokyo, 169-0051
  • Japan
Primary Industry
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • Waseda University Entrepreneurship Center
  • 1-22-3 Nishiwaseda, Shinjuku-ku
  • Tokyo, 169-0051
  • Japan

BioPhenoMA Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioPhenoMA Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Accelerator/Incubator 03-Dec-2024 Completed Generating Revenue
5. Early Stage VC 07-Nov-2024 Completed Generating Revenue
4. Seed Round 24-May-2023 Completed Startup
3. Accelerator/Incubator Completed Startup
2. Accelerator/Incubator Completed Startup
1. Accelerator/Incubator Completed Startup
To view BioPhenoMA’s complete valuation and funding history, request access »

BioPhenoMA Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Pre-A Preferred
Preference
To view BioPhenoMA’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

BioPhenoMA Patents

  • 11

    Total Documents Applications and Grants

  • Total Patents Families

  • 10

    Granted

  • Pending

  • Expiring in next 12 mo

BioPhenoMA Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025142889-A1 Device for classifying extracellular vesicles, and in vitro method for classifying extracellular vesicles and detecting or analyzing proteins contained in extracellular vesicles Inactive 25-Dec-2023
EP-3438279-A1 Method for measuring protein and nucleic acid with ultrahigh sensitivity Active 30-Mar-2016
EP-3438279-A4 Method for measuring protein and nucleic acid with ultrahigh sensitivity Active 30-Mar-2016
EP-3438279-B1 Method for measuring protein and nucleic acid with ultrahigh sensitivity Active 30-Mar-2016
EP-3438279-C0 Method for measuring protein and nucleic acid with ultrahigh sensitivity Active 30-Mar-2016 C12Q1/32
To view BioPhenoMA’s complete patent history, request access »

BioPhenoMA Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioPhenoMA Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Plug and Play Accelerator/Incubator
JMTC Capital Corporate Venture Capital Minority
Waseda University Ventures Venture Capital Minority
LINK-J Accelerator/Incubator
NEXs Tokyo Accelerator/Incubator
To view BioPhenoMA’s complete investors history, request access »

Ready to get started?

Request a free trial

BioPhenoMA FAQs

  • When was BioPhenoMA founded?

    BioPhenoMA was founded in 2023.

  • Where is BioPhenoMA headquartered?

    BioPhenoMA is headquartered in Tokyo, Japan.

  • What is the size of BioPhenoMA?

    BioPhenoMA has 3 total employees.

  • What industry is BioPhenoMA in?

    BioPhenoMA’s primary industry is Biotechnology.

  • Is BioPhenoMA a private or public company?

    BioPhenoMA is a Private company.

  • What is BioPhenoMA’s current revenue?

    The current revenue for BioPhenoMA is .

  • How much funding has BioPhenoMA raised over time?

    BioPhenoMA has raised $2.73M.

  • Who are BioPhenoMA’s investors?

    Plug and Play, JMTC Capital, Waseda University Ventures, LINK-J, and NEXs Tokyo have invested in BioPhenoMA.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process